Tag Archives: Cluster

FDA Approves Emgality (galcanezumab-gnlm) for the Treatment of Episodic Cluster Headache

Print this page INDIANAPOLIS, June 04, 2019 – Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality (galcanezumab-gnlm) injection (300 mg) for the treatment of episodic cluster headache in adults.1 Emgality is an innovative therapeutic approach for this neurologic disease and the first and only… Read More »

electroCore Vagus Nerve Stimulator Cleared for Prevention of Cluster Headache

electroCore, based out of Basking Ridge, New Jersey, received the first FDA clearance for a product to prevent cluster headache. The gammaCore non-invasive vagus nerve stimulation (nVNS) system was previously cleared for treating pain that has already kicked in, that is related to migraines and episodic cluster headaches. The new clearance means that doctors can prescribe it… Read More »